sonar-pro
Permits stability data submission for pharmaceutical products at 25°C/60% relative humidity (RH) when supported by accelerated stability studies.
{
  "id": "075648d6-bb0b-4490-ae0f-7e863e527104",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"status\":\"PARTIAL\",\"explanation\":\"Thailand generally follows ASEAN stability guidelines, which accept 25°C/60% RH as a long-term stability testing condition, but data solely at 25°C/60% RH—even when supported by accelerated studies—may be rejected as 'less stressful' than the preferred 30°C/75% RH for Zone IVb (Thailand's climatic zone); additional justification or intermediate condition data may be required if significant changes are observed during accelerated testing[5][1].\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755750131,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 106,
    "prompt_tokens": 31,
    "total_tokens": 137,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://www.artixio.com/post/thailand-fda-regulations-for-pharmaceutical-registration",
    "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
    "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
    "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
    "https://asean.org/wp-content/uploads/2018/01/25PPWG-ANNEX-7-iv-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2.pdf"
  ],
  "search_results": [
    {
      "title": "Thai FDA Pharma Regulations & Registration Process in ...",
      "url": "https://www.artixio.com/post/thailand-fda-regulations-for-pharmaceutical-registration",
      "date": "2025-08-04",
      "last_updated": "2025-06-22"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "https://www.rsc.org/suppdata/c5/ra/c5ra07716h/c5ra07716h1.pdf",
      "date": null,
      "last_updated": "2025-03-27"
    },
    {
      "title": "Annex 2 Stability testing of active pharmaceutical ...",
      "url": "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "ich-q-1-r2-stability-testing-new-drug-substances-and-products ...",
      "url": "https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "asean guideline on stability study of drug product",
      "url": "https://asean.org/wp-content/uploads/2018/01/25PPWG-ANNEX-7-iv-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2.pdf",
      "date": "1997-07-02",
      "last_updated": "2025-08-10"
    }
  ]
}